#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14298	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2125	669.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1408	1408	C	920	C	840	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14298	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2125	669.3	0	HET	.	.	.	C1450T	.	1450	1450	C	1674	1674	C	802	C,T	589,144	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26594	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3438	769.7	0	.	n	.	0	T695C	SNP	695	695	T	1042	1042	C	832	C,T	752,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26594	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3438	769.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1684	1684	A	863	A,G	797,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26594	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3438	769.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2318	2318	C	825	C	765	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26594	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3438	769.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2392	2392	A	872	A	809	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26594	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3438	769.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2944	2944	C	811	C	751	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	1788	folP	855	855	99.88	folP.l15.c17.ctg.1	1530	116.2	0	.	p	.	0	E152K	NONSYN	454	456	GAA	816	818	AAA	185;184;185	A;A;A	169;167;167	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	1788	folP	855	855	99.88	folP.l15.c17.ctg.1	1530	116.2	1	SNP	p	R229S	0	.	.	685	687	CGC	1047	1049	CGC	187;189;189	C;G;C	174;178;178	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4458	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3376	131.7	1	SNP	p	S91F	0	.	.	271	273	TCC	696	698	TCC	173;174;172	T;C;C	153;157;155	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4458	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3376	131.7	1	SNP	p	D95N	0	.	.	283	285	GAC	708	710	GAC	169;169;171	G;A;C	154;152;154	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4458	gyrA	2751	2751	99.89	gyrA.l6.c4.ctg.1	3376	131.7	1	SNP	p	D95G	0	.	.	283	285	GAC	708	710	GAC	169;169;171	G;A;C	154;152;154	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1504	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1289	116.4	1	SNP	p	G45D	1	.	.	133	135	GAC	436	438	GAC	217;218;214	G;A;C,A	198;193;193,1	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	750	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	981	76.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4532	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3098	145.7	1	SNP	p	D86N	0	.	.	256	258	GAC	588	590	GAC	200;196;196	G;A;C	180;175;178	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4532	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3098	145.7	1	SNP	p	S88P	0	.	.	262	264	TCC	594	596	TCC	193;193;189	T;C;C	178;178;175	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3950	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2403	163.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1433	1435	GGC	207;206;204	G;G;C	190;188;185	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1220	1222	GCA	205;207;205	G;C;A	188;188;188	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1223	1225	ATC	206;206;207	A;T;C	186;184;186	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1235	1237	GTG	211;212;212	G;T;G	186;185;187	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1235	1237	GTG	211;212;212	G;T;G	186;185;187	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1739	1741	ACC	196;195;195	A;C;C	170;175;175	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1793	1795	GCG	177;178;180	G;C,G;G	162;146,1;155	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1793	1795	GCG	177;178;180	G;C,G;G	162;146,1;155	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1916	1918	GGC	155;154;154	G;G;C,T	143;142;139,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1925	1927	GGC	151;150;150	G;G;C	132;131;131	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3718	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2406	153.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1943	1945	CTG	135;137;137	C,CG;T;GCCC,GCCCC	105,1;99;99,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5172	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3040	169.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1574	1576	CCG	173;173;176	C,G;C;G	150,1;156;155	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1938	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1797	107.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	358	360	GGC	135;136;134	G;G;C	119;119;118	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1938	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1797	107.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	540	540	C	148	C	135	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	E38G	NONSYN	112	114	GAA	348	350	GGA	275;272;274	G;G;A	247;244;245	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	G46S	NONSYN	136	138	GGC	372	374	AGC	249;248;251	A;G;C,T	229;227;229,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	V98I	NONSYN	292	294	GTC	528	530	ATC	223;221;222	A;T;C	209;209;212	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	A121V	NONSYN	361	363	GCC	597	599	GTC	236;236;237	G;T;C	218;214;218	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	R143E	NONSYN	427	429	AGA	663	665	GAA	240;242;241	G;A;A	219;220;218	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	N212_S213insNQFY	INS	634	634	A	870	870	A	227	A	212	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	L218F	NONSYN	652	654	CTT	900	902	TTT	232;234;234	T;T;T	218;221;219	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	W253L	NONSYN	757	759	TGG	1005	1007	TTG	209;211;211	T;T,G;G	194;195,1;197	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	S254H	NONSYN	760	762	AGT	1008	1010	CAT	214;215;215	C;A,G;T	200;199,1;202	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	H290R	NONSYN	868	870	CAT	1116	1118	CGT	242;242;240	C;G;T	219;218;217	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2848	porB1b	1035	1035	97.61	porB1b.l15.c30.ctg.1	1423	199.2	0	.	p	.	0	E329D	NONSYN	985	987	GAA	1233	1235	GAC	249;245;244	G;A;C	232;231;229	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10570	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4783	220.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1034	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1006	102.5	1	SNP	p	V57M	1	.	.	169	171	ATG	501	503	ATG	223;224;222	A;T;G	202;202;197	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
